Comparison of Herpes Zoster Ophthalmicus in Patients 60 Years Older Versus Younger than 60 Years

[1]  E. Cohen,et al.  Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years. , 2011, Ophthalmology.

[2]  Yoo-Ri Chung,et al.  Ocular Manifestations of Herpes Zoster Ophthalmicus , 2010 .

[3]  S. Y. Kim,et al.  The Clinical Characteristics of Facial Herpes Zoster in Korean Patients , 2010 .

[4]  J. Sohn,et al.  Adult Immunization Schedule Recommended by the Korean Society of Infectious Diseases, 2007 , 2008 .

[5]  S. Kaufman.  Anterior segment complications of herpes zoster ophthalmicus. , 2008, Ophthalmology.

[6]  T. Liesegang.  Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. , 2008, Ophthalmology.

[7]  A. Arvin.  Aging, immunity, and the varicella-zoster virus. , 2005, The New England journal of medicine.

[8]  P. Peduzzi,et al.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.

[9]  T. Hampton.  When Shingles Wanes But Pain Does Not , 2005 .

[10]  K. Schmader,et al.  Treatment and prevention of postherpetic neuralgia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  H. Völker‐Dieben,et al.  Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  R. Whitley,et al.  Clinical practice. Herpes zoster. , 2002, The New England journal of medicine.

[13]  R. Dworkin,et al.  Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. , 2002, Journal of the American Academy of Dermatology.

[14]  W. Edmunds,et al.  Epidemiology of varicella zoster virus infection in Canada and the United Kingdom , 2001, Epidemiology and Infection.

[15]  R. Dworkin,et al.  Pain and its persistence in herpes zoster , 1996, Pain.

[16]  S. Straus,et al.  Postherpetic neuralgia--pathogenesis, treatment, and prevention. , 1996, The New England journal of medicine.

[17]  A. Arvin,et al.  Varicella-zoster virus , 1996, Clinical microbiology reviews.

[18]  M. Oxman.  Immunization to reduce the frequency and severity of herpes zoster and its complications , 1995, Neurology.

[19]  J. Manson,et al.  The incidence of herpes zoster. , 1995, Archives of internal medicine.

[20]  Jennifer Y. Liu,et al.  Herpes zoster and human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.

[21]  Nauss La,et al.  Treatment of acute herpetic neuralgia. A case report and review of the literature. , 1990 .

[22]  Philip R. Cohen,et al.  Clinical features of human immunodeficiency virus‐associated disseminated herpes zoster virus infection–a review of the literature , 1989, Clinical and experimental dermatology.

[23]  B. Cho,et al.  A Clinical Study of Herpes Zoster Ophthalmicus , 1988 .

[24]  L. Melton,et al.  Population‐Based Study of Herpes Zoster and Its Sequelae , 1982, Medicine.

[25]  L. Melton,et al.  Risk of cancer after herpes zoster: a population-based study. , 1982, The New England journal of medicine.

[26]  T. D. Cain,et al.  Immune responses to varicella-zoster in the aged. , 1982, Archives of Internal Medicine.

[27]  H. B. Ostler,et al.  The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus disease. , 1976, Survey of ophthalmology.

[28]  R. Kierland,et al.  The outcome of patients with herpes zoster. , 1957, A.M.A. archives of dermatology.